REPORT ID 6631

Asia-Pacific Bioengineered Protein Drugs Market Report 2017

Publish Date
26-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the Asia-Pacific Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Bioengineered Protein Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Bioengineered Protein Drugs market competition by top manufacturers/players, with Bioengineered Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    F. Hoffmann-La Roche Ltd
    Amgen, Inc.
    Bayer AG
    Merck & Co., Inc.
    Dr. Reddy?s Laboratories Ltd.
    Biocon Ltd.
    Eli Lilly and Company
    Sanofi
    GlaxoSmithKline plc
    Johnson & Johnson
    JanssenNovartis AG
    Panacea Biotec
    ProBioGen AG

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Therapeutic Proteins
    Monoclonal Antibodies
    Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Diabetes and Hormonal Disorders
    Genetic and Fertility Disorders
    Cancers
    Organ Transplants
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Bioengineered Protein Drugs Market Report 2017
1 Bioengineered Protein Drugs Overview
    1.1 Product Overview and Scope of Bioengineered Protein Drugs
    1.2 Classification of Bioengineered Protein Drugs by Product Category
        1.2.1 Asia-Pacific Bioengineered Protein Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Bioengineered Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Therapeutic Proteins
        1.2.4 Monoclonal Antibodies
        1.2.5 Vaccines
    1.3 Asia-Pacific Bioengineered Protein Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Bioengineered Protein Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Diabetes and Hormonal Disorders
        1.3.3 Genetic and Fertility Disorders
        1.3.4 Cancers
        1.3.5 Organ Transplants
        1.3.6 Others
    1.4 Asia-Pacific Bioengineered Protein Drugs Market by Region
        1.4.1 Asia-Pacific Bioengineered Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Bioengineered Protein Drugs (2012-2022)
        1.5.1 Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Bioengineered Protein Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Bioengineered Protein Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Bioengineered Protein Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Bioengineered Protein Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Bioengineered Protein Drugs (Volume) by Application
    2.4 Asia-Pacific Bioengineered Protein Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Bioengineered Protein Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Market Share by Region (2012-2017)

3 China Bioengineered Protein Drugs (Volume, Value and Sales Price)
    3.1 China Bioengineered Protein Drugs Sales and Value (2012-2017)
        3.1.1 China Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    3.2 China Bioengineered Protein Drugs Sales Volume and Market Share by Type
    3.3 China Bioengineered Protein Drugs Sales Volume and Market Share by Application

4 Japan Bioengineered Protein Drugs (Volume, Value and Sales Price)
    4.1 Japan Bioengineered Protein Drugs Sales and Value (2012-2017)
        4.1.1 Japan Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    4.2 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Type
    4.3 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Application

5 South Korea Bioengineered Protein Drugs (Volume, Value and Sales Price)
    5.1 South Korea Bioengineered Protein Drugs Sales and Value (2012-2017)
        5.1.1 South Korea Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    5.2 South Korea Bioengineered Protein Drugs Sales Volume and Market Share by Type
    5.3 South Korea Bioengineered Protein Drugs Sales Volume and Market Share by Application

6 Taiwan Bioengineered Protein Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Bioengineered Protein Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan Bioengineered Protein Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Bioengineered Protein Drugs Sales Volume and Market Share by Application

7 India Bioengineered Protein Drugs (Volume, Value and Sales Price)
    7.1 India Bioengineered Protein Drugs Sales and Value (2012-2017)
        7.1.1 India Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    7.2 India Bioengineered Protein Drugs Sales Volume and Market Share by Type
    7.3 India Bioengineered Protein Drugs Sales Volume and Market Share by Application

8 Southeast Asia Bioengineered Protein Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Bioengineered Protein Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Application

9 Australia Bioengineered Protein Drugs (Volume, Value and Sales Price)
    9.1 Australia Bioengineered Protein Drugs Sales and Value (2012-2017)
        9.1.1 Australia Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Bioengineered Protein Drugs Sales Price Trend (2012-2017)
    9.2 Australia Bioengineered Protein Drugs Sales Volume and Market Share by Type
    9.3 Australia Bioengineered Protein Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data
    10.1 Abbott Laboratories
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 F. Hoffmann-La Roche Ltd
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Amgen, Inc.
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Bayer AG
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Bayer AG Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Merck & Co., Inc.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Dr. Reddy?s Laboratories Ltd.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Dr. Reddy?s Laboratories Ltd. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Biocon Ltd.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Eli Lilly and Company
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Sanofi
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Sanofi Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 GlaxoSmithKline plc
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Bioengineered Protein Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Johnson & Johnson
    10.12 JanssenNovartis AG
    10.13 Panacea Biotec
    10.14 ProBioGen AG

11 Bioengineered Protein Drugs Manufacturing Cost Analysis
    11.1 Bioengineered Protein Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Bioengineered Protein Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Bioengineered Protein Drugs Market Forecast (2017-2022)
    15.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Bioengineered Protein Drugs Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Bioengineered Protein Drugs Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        1